Collegium Pharmaceutical (COLL) Other Non-Current Assets (2014 - 2026)

Collegium Pharmaceutical's Other Non-Current Assets history runs 13 years deep, the most recent figure standing at $16.1 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 1434.29% year-over-year to $16.1 million; the TTM figure through Mar 2026 stood at $16.1 million (up 1434.29% YoY), while the FY2025 annual figure was $1.1 million, down 87.38% from the prior year.
• Other Non-Current Assets was $16.1 million for Q1 2026 at Collegium Pharmaceutical, up from $1.1 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $16.1 million in Q1 2026 to a low of $825000.0 in Q4 2023.
• Historically, Other Non-Current Assets has averaged $2.9 million across 5 years, with a median of $1.1 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Other Non-Current Assets tumbled 87.38% in 2025, then surged 1434.29% in 2026.
• A 5-year view of Other Non-Current Assets shows it stood at $2.5 million in 2022, then tumbled by 67.61% to $825000.0 in 2023, then jumped by 914.3% to $8.4 million in 2024, then sank by 87.38% to $1.1 million in 2025, then soared by 1421.21% to $16.1 million in 2026.
• The last three Other Non-Current Assets figures came in at $16.1 million (Q1 2026), $1.1 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.